WEKO3
アイテム
{"_buckets": {"deposit": "d49ee5d7-7053-4100-8d5f-d543e73b01c6"}, "_deposit": {"created_by": 1, "id": "54301", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "54301"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00054301", "sets": ["2"]}, "author_link": ["554640", "554643", "554644", "554646", "554642", "554641", "554647", "554645"], "item_10003_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2010", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "235", "bibliographicPageEnd": "53", "bibliographicPageStart": "44", "bibliographicVolumeNumber": "NIRS-M", "bibliographic_titles": [{"bibliographic_title": "Proceedings of Japanease-European Joint Symposium on Ion Cancer Therapy and NIRS-KI Joint Symposium on Ion-Radiation Sciences, September 9 \u0026 10-11, 2010 Karolinska University Hospital, Solna Stockholm, Sweden Organized by National Institute of Radiological Sciences, Japan and Karolinska Institute, Sweden"}]}]}, "item_10003_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Purpose: An up-to-date analysis of the results of hypofractionated conformal carbon ion radiotherapy (C-ion RT) for localized prostate cancer was performed to determine the normal tissue morbidity, biochemical relapse-free rate (bNED), and patient survival. \nMethods and Materials: Nine hundred and three prostate cancer patients who received the C-ion RT that had been established by two prior dose-escalation studies were analyzed with regard to toxicity, survival, and bNED. \nResults: Only 1 out of 818 patients followed up for at least 12 months developed grade 3 genitourinary toxicity, and no grade 3 or higher toxicities were observed in the rectum. The incidence of grade 2 rectum and GU morbidity were only 2.0% and 5.6%, respectively. The incidence of late toxicity in the patients treated with C-ion RT for 16 fractions was lower than that for patients who received 20 fractions. The overall bNED at 5 years was 90.9%, with only five local recurrences. The bNED of the 16-fraction C-ion RT was comparable to that of 20 fractions. The Gleason\u0027s score, T-stage, and initial PSA were significant prognostic factors for bNED, and the T-stage and initial PSA were also significant prognostic factors for the overall survival rate. C-ion RT with the established dose fractionation regimen yielded satisfactory bNED with very few local recurrences, and with minimal morbidity. Therefore, C-ion RT in 16 fractions could offer an even lower incidence of toxicities than 20 fractions, without any decrease in the biochemical control of the disease.", "subitem_description_type": "Abstract"}]}, "item_10003_publisher_8": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "National Institute of Radiological Sciences"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Tsuji, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "554640", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Okada, Tohru"}], "nameIdentifiers": [{"nameIdentifier": "554641", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kamada, Tadashi"}], "nameIdentifiers": [{"nameIdentifier": "554642", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsujii, Hirohiko"}], "nameIdentifiers": [{"nameIdentifier": "554643", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "辻 比呂志", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "554644", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "岡田 徹", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "554645", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "鎌田 正", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "554646", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "辻井 博彦", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "554647", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference paper", "resourceuri": "http://purl.org/coar/resource_type/c_5794"}]}, "item_title": "Carbon Ion Radiotherapy for Prostate Cancer", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Carbon Ion Radiotherapy for Prostate Cancer"}]}, "item_type_id": "10003", "owner": "1", "path": ["2"], "permalink_uri": "https://repo.qst.go.jp/records/54301", "pubdate": {"attribute_name": "公開日", "attribute_value": "2011-11-21"}, "publish_date": "2011-11-21", "publish_status": "0", "recid": "54301", "relation": {}, "relation_version_is_last": true, "title": ["Carbon Ion Radiotherapy for Prostate Cancer"], "weko_shared_id": -1}
Carbon Ion Radiotherapy for Prostate Cancer
https://repo.qst.go.jp/records/54301
https://repo.qst.go.jp/records/54301fd06c91c-7272-48a1-9a6f-d06e5780b29b
Item type | 会議発表論文 / Conference Paper(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2011-11-21 | |||||
タイトル | ||||||
タイトル | Carbon Ion Radiotherapy for Prostate Cancer | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_5794 | |||||
資源タイプ | conference paper | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Tsuji, Hiroshi
× Tsuji, Hiroshi× Okada, Tohru× Kamada, Tadashi× Tsujii, Hirohiko× 辻 比呂志× 岡田 徹× 鎌田 正× 辻井 博彦 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Purpose: An up-to-date analysis of the results of hypofractionated conformal carbon ion radiotherapy (C-ion RT) for localized prostate cancer was performed to determine the normal tissue morbidity, biochemical relapse-free rate (bNED), and patient survival. Methods and Materials: Nine hundred and three prostate cancer patients who received the C-ion RT that had been established by two prior dose-escalation studies were analyzed with regard to toxicity, survival, and bNED. Results: Only 1 out of 818 patients followed up for at least 12 months developed grade 3 genitourinary toxicity, and no grade 3 or higher toxicities were observed in the rectum. The incidence of grade 2 rectum and GU morbidity were only 2.0% and 5.6%, respectively. The incidence of late toxicity in the patients treated with C-ion RT for 16 fractions was lower than that for patients who received 20 fractions. The overall bNED at 5 years was 90.9%, with only five local recurrences. The bNED of the 16-fraction C-ion RT was comparable to that of 20 fractions. The Gleason's score, T-stage, and initial PSA were significant prognostic factors for bNED, and the T-stage and initial PSA were also significant prognostic factors for the overall survival rate. C-ion RT with the established dose fractionation regimen yielded satisfactory bNED with very few local recurrences, and with minimal morbidity. Therefore, C-ion RT in 16 fractions could offer an even lower incidence of toxicities than 20 fractions, without any decrease in the biochemical control of the disease. |
|||||
書誌情報 |
Proceedings of Japanease-European Joint Symposium on Ion Cancer Therapy and NIRS-KI Joint Symposium on Ion-Radiation Sciences, September 9 & 10-11, 2010 Karolinska University Hospital, Solna Stockholm, Sweden Organized by National Institute of Radiological Sciences, Japan and Karolinska Institute, Sweden 巻 NIRS-M, 号 235, p. 44-53, 発行日 2010 |
|||||
出版者 | ||||||
出版者 | National Institute of Radiological Sciences |